Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honglin Hu

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Current Stem Cell Research & Therapy|October 27, 2016
Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic PerspectivesHonglin Hu, Cong Zou
The Lancet. Oncology|September 4, 2025
Reflecting on the patient-reported outcomes from the EV-302 trialJun Li, Honglin Hu
Vascular Health and Risk Management|September 12, 2013
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular riskCong Zou, Honglin Hu
The Journal of Clinical Endocrinology and Metabolism|August 25, 2012
Giant adrenal angiomyolipomaHonglin Hu, Xiaoqing Xi
The New England Journal of Medicine|April 24, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. ReplyYeming Wang, Honglin Hu, Bin Cao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2026
Focal Boosting in Localized Prostate Cancer in the Era of Systemic Therapy and Prostate-Specific Membrane Antigen ImagingYunfeng Zhang, Xing Wang, Honglin Hu
Fertility and Sterility|December 6, 2025
Refining exposure definition and follow-up timing to improve clinical interpretability of familial mortality risksYunfeng Zhang, Jun Li, Honglin Hu
Biochemical and Biophysical Research Communications|February 7, 2015
rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expressionYing Deng, Hansong Bai, Honglin Hu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2025
Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial InsightsJun Li, Ruizhen Huang, Honglin Hu
European Urology|September 9, 2025
Re: Metformin for Patients with Metastatic Prostate Cancer Starting Androgen Deprivation Therapy: A Randomised Phase 3 Trial of the STAMPEDE Platform ProtocolJun Li, Yunfeng Zhang, Honglin Hu
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Current Stem Cell Research & Therapy|October 27, 2016
Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic PerspectivesHonglin Hu, Cong Zou
The Lancet. Oncology|September 4, 2025
Reflecting on the patient-reported outcomes from the EV-302 trialJun Li, Honglin Hu
Vascular Health and Risk Management|September 12, 2013
Use of pioglitazone in the treatment of diabetes: effect on cardiovascular riskCong Zou, Honglin Hu
The Journal of Clinical Endocrinology and Metabolism|August 25, 2012
Giant adrenal angiomyolipomaHonglin Hu, Xiaoqing Xi
The New England Journal of Medicine|April 24, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. ReplyYeming Wang, Honglin Hu, Bin Cao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2026
Focal Boosting in Localized Prostate Cancer in the Era of Systemic Therapy and Prostate-Specific Membrane Antigen ImagingYunfeng Zhang, Xing Wang, Honglin Hu
Fertility and Sterility|December 6, 2025
Refining exposure definition and follow-up timing to improve clinical interpretability of familial mortality risksYunfeng Zhang, Jun Li, Honglin Hu
Biochemical and Biophysical Research Communications|February 7, 2015
rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expressionYing Deng, Hansong Bai, Honglin Hu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2025
Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial InsightsJun Li, Ruizhen Huang, Honglin Hu
European Urology|September 9, 2025
Re: Metformin for Patients with Metastatic Prostate Cancer Starting Androgen Deprivation Therapy: A Randomised Phase 3 Trial of the STAMPEDE Platform ProtocolJun Li, Yunfeng Zhang, Honglin Hu
Pageof 12